JudithCLinMD

Hematology • Lexington, KY

Clotting Disorder, Hemophilia & Bleeding Disorder

Assistant Professor

Join to view full profile

Dr. Lin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lin's full profile

Already have an account?

Office
800 Rose St Roach Cancer Ctr 1st FL
Lexington, KY 40536
Phone+1 859-257-6006

Fax+1 859-257-6002

Education & Training

Beth Israel Deaconess Medical CenterPost-Doctoral Fellowship, 1999 - 2005
Orthopaedic Institute for ChildrenPost-Doctoral Fellowship, 1997 - 1998
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1995 - 1997
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1992 - 1995
Stony Brook University Health Sciences Center School of MedicineClass of 1992
Massachusetts Institute of TechnologySB & SB, Chemistry & Life Science

Certifications & Licensure

NY State Medical License 1993 - 2026
CA State Medical License 1993 - 2025
KY State Medical License 2024 - 2025
MA State Medical License 1999 - 2024
ME State Medical License 2022 - 2023
WA State Medical License 2019 - 2022
OR State Medical License 2019 - 2021
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Safety and Efficacy of Autologous Concentrated Bone Marrow Aspirate for Critical Limb Ischemia - Continued Access
No longer available

Publications & Presentations

PubMed

52 citations
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: Results from a multicenter, randomized, controlled trial of vatreptacog alfa
Steven R. Lentz, Silke Ehrenforth, F. Abdul Karim, Tadashi Matsushita, K. N. Weldingh
Journal of Thrombosis and Haemostasis. 2014-08-01
8 citations
Patient characteristics that influence efficacy of prophylaxis with rFVIII‐FS three times per week: a subgroup analysis of the LIPLONG study
Shadan Lalezari, A. Coppola, J. C. Lin, Monika Maas Enriquez, D. Tseneklidou-Stoeter
Haemophilia. 2014-05-01
128 citations
Phase I study of BAY 94‐9027, a PEGylated B‐domain‐deleted recombinant factor VIII with an extended half‐life, in subjects with hemophilia A
T. E. Coyle, Mark T. Reding, J. C. Lin, L. A. Michaels, A. Shah
Journal of Thrombosis and Haemostasis. 2014-04-01